Why did PBH's Q1 2025 earnings exceed forecasts?

Prestige Consumer Healthcare Inc. (PBH) reported its Q1 2025 earnings, which exceeded forecasts due to several key factors:

1. **Strong International Business Performance**: The company's international business showed significant growth, particularly in Australia, driven by the performance of the Hydralyte® brand. This strong international performance contributed to the overall revenue outperformance.
2. **Clear Eyes Brand Improvement**: There was an improvement in sales from the Clear Eyes brand, which is a positive indicator for the company's performance. This improvement, along with the strong international business, contributed to the better-than-expected earnings.
3. **Strategic Acquisitions**: Prestige Consumer Healthcare has been focusing on strategic acquisitions to bolster its product offerings. These acquisitions are likely to have contributed to the company's growth and profitability.

In summary, Prestige Consumer Healthcare's Q1 2025 earnings exceeded forecasts due to strong international business performance, particularly in Australia, improvement in sales from the Clear Eyes brand, and the impact of strategic acquisitions. These factors, combined with effective market positioning and regional brand strategies, have positioned the company for continued growth and profitability.